Industry Relations With Emergency Medicine Graduate Medical Education Programs
dc.contributor.author | Kowalenko, Terry | en_US |
dc.contributor.author | Char, Douglas | en_US |
dc.contributor.author | Marco, Catherine | en_US |
dc.contributor.author | Asher, Shellie | en_US |
dc.contributor.author | Raja, Ali S. | en_US |
dc.contributor.author | Farrell, Sue | en_US |
dc.contributor.author | Sokolove, Peter E. | en_US |
dc.date.accessioned | 2010-06-01T18:59:02Z | |
dc.date.available | 2010-06-01T18:59:02Z | |
dc.date.issued | 2009-10 | en_US |
dc.identifier.citation | Kowalenko, Terry; Char, Douglas; Marco, Catherine; Asher, Shellie; Raja, Ali; Farrell, Sue; Sokolove, Peter E. (2009). "Industry Relations With Emergency Medicine Graduate Medical Education Programs." Academic Emergency Medicine 16(10): 1025-1030. <http://hdl.handle.net/2027.42/72174> | en_US |
dc.identifier.issn | 1069-6563 | en_US |
dc.identifier.issn | 1553-2712 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72174 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19799581&dopt=citation | en_US |
dc.format.extent | 71690 bytes | |
dc.format.extent | 104309 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © 2009 Society for Academic Emergency Medicine | en_US |
dc.subject.other | Pharmaceutical Industry | en_US |
dc.subject.other | Graduate Medical Education | en_US |
dc.title | Industry Relations With Emergency Medicine Graduate Medical Education Programs | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 19799581 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72174/1/j.1553-2712.2009.00539.x.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72174/2/ACEM_539_sm_DataSupplementS1.pdf | |
dc.identifier.doi | 10.1111/j.1553-2712.2009.00539.x | en_US |
dc.identifier.source | Academic Emergency Medicine | en_US |
dc.identifier.citedreference | Hammond C. In the business. Endeavors magazine. Chapel Hill, NC: University of North Carolina at Chapel Hill, 1999. Available at: http://research.unc.edu/endeavors/fall99/business.htm. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Ross J, Lurie P, Wolfe S. Medical education service suppliers: a threat to physician education. Public Citizen’s Health Research Group, 2000. Available at: http://www.citizen.org/publications/release.cfm?ID=7142. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | The Pharmaceutical Research and Manufacturers of America (PhRMA). New Medicines New Hope Annual report, 2008. Available at: http://www.phrma.org/files/PhRMA_annualreportFianl.pdf. Accessed Jul 28, 2009. | en_US |
dc.identifier.citedreference | IMS HEALTH Reports U.S. Pharmaceutical Promotional Spending Topped $8 Billion in First-half 2000. Pharmaceutical Representative. June 9, 2000. Business Wire Oct 19, 2000. Available at: http://www.highbeam.com/doc/1G1-66223423.html. Accessed Jul 28, 2009. | en_US |
dc.identifier.citedreference | Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000; 283: 373 – 80. | en_US |
dc.identifier.citedreference | Randall T. Kennedy hearings say no more free lunch–or much else–from drug firms. JAMA. 1991; 265: 440 – 2. | en_US |
dc.identifier.citedreference | Chren M, Lansdefeld C. Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994; 271: 684 – 9. | en_US |
dc.identifier.citedreference | Orlowski J, Watska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest. 1992; 102: 270 – 3. | en_US |
dc.identifier.citedreference | American College of Emergency Physicians. Code of Ethics for Emergency Physicians. Revised and approved by the ACEP Board of Directors June 2008. Available at: http://www.acep.org/practres.aspx?id=29144. Accessed Aug 29, 2009. | en_US |
dc.identifier.citedreference | Stern D. In search of the informal curriculum: when and where professional values are taught. Acad Med. 1998; 73 ( 10 Suppl 1 ): LS-28 – 30. | en_US |
dc.identifier.citedreference | Rennie D. Thyroid storm. JAMA. 1997; 277: 1238 – 43. | en_US |
dc.identifier.citedreference | Relman A. Separating continuing medical education from pharmaceutical marketing. JAMA. 2001; 285: 2009 – 12. | en_US |
dc.identifier.citedreference | American Medical Association. Council on Ethical and Judicial Affairs. Gifts to physicians from industry. JAMA. 1991; 266: 501. | en_US |
dc.identifier.citedreference | Coyle SL, for the Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 1: Individual physicians. Ann Intern Med. 2002; 136: 396 – 402. | en_US |
dc.identifier.citedreference | Coyle SL, for the Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 2: Organizational issues. Ann Intern Med. 2002; 136: 403 – 6. | en_US |
dc.identifier.citedreference | Canadian Medical Association. Guidelines for physicians in interactions with industry. 2007. Available at: http://policybase.cma.ca/dbtw-wpd/Policypdf/PD08-01.pdf. Accessed Jul 28, 2009. | en_US |
dc.identifier.citedreference | Accreditation Council for Continuing Medical Education. Standards to ensure the independence of CME activities. Available at: http://www.accme.org/dir_docs/doc_upload/68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Association of American Medical Colleges. Task force on financial conflicts of interest in research. Protecting subjects, preserving trust, promoting progress: policy and guidelines for the oversight of individual financial interests in human subject research. Available at: http://www.aamc.org/research/coi/firstreport.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Available at: http://www.phrma.org/code_on_interactions_with_healthcare_professionals/. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Accreditation Council on Graduate Medical Education. Principles to guide the relationship between graduate medical education and industry. Sept 10, 2002. Available at: http://www.acgme.org/acWebsite/positionPapers/pp_GMEGuide.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Keim S, Perina DG, on behalf of the CORD Board of Directors. Council of Emergency Medicine Residency Directors Position on Interactions Between Emergency Medicine Residencies and the Pharmaceutical Industry. Acad Emerg Med. 2004; 11: 78. | en_US |
dc.identifier.citedreference | Schears RM, Watters A, Schmidt TA, et al. The Society of Academic Emergency Medicine Position on Ethical Relationships with Biomedical Industry. Acad Emerg Med. 2007; 14: 179 – 81. | en_US |
dc.identifier.citedreference | Poll Harris. Oil, pharmaceutical, health insurance, managed care, utilities and tobacco top the list of industries that many people think need more regulation. Nov 1, 2007. Available at: http://www.harrisinteractive.com/harris_poll/index.asp?PID=825. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Association of American Medical Colleges Task Force. Industry Funding of Medical Education: Report of the AAMC Task Force. June 2008. Available at: https://services.aamc.org/publications/showfile.cfm?file=version114.pdf&prd_id=232&prv_id=281&pdf_id=114. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | American Medical Association. Report of the Council on Ethical and Judicial Affairs and the Council on Medical Education. Industry Support of Professional Education in Medicine. Available at: http://www.ama-assn.org/ama1/pub/upload/mm/369/ceja-cme_1i08.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Institute of Medicine. Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press, 2009. | en_US |
dc.identifier.citedreference | Accreditation Council for Continuing Medical Education (ACCME). The ACCME’s essential areas and their elements. 2008. Available at: http://www.accme.org/dir_docs/doc_upload/f4ee5075-9574-4231-8876-5e21723c0c82_uploaddocument.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med. 2004; 11: 19 – 26. | en_US |
dc.identifier.citedreference | Rothman DJ, McDonald WJ, Berkowitz CD, et al. Professional medical associations and their relationship with industry: a proposal for controlling conflict of interest. JAMA. 2009; 301: 1367 – 72. | en_US |
dc.identifier.citedreference | Steinbrook R. Controlling conflict of interest-proposals from the Institute of Medicine. N Engl J Med. 2009; 360: 2160 – 3. | en_US |
dc.identifier.citedreference | Kuehn BM. Pharmaceutical industry funding for residencies sparks controversy. JAMA. 2005; 293: 1572. 1579–80. | en_US |
dc.identifier.citedreference | Brody H. Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry. New York, NY: Rowan & Littlefield, 2006. | en_US |
dc.identifier.citedreference | Accreditation Council for Continuing Medical Education. ACCME Annual Report Data 2006. Available at: http://www.accme.org/dir_docs/doc_upload/f51ed7d8-e3b4-479a-a9d8-57b6efedc27a_uploaddocument.pdf. Accessed Jul 18, 2009. | en_US |
dc.identifier.citedreference | Stern D, Papadakis M. The developing physician – becoming a professional. N Engl J Med. 2006; 35: 1794 – 9. | en_US |
dc.identifier.citedreference | McCormick B, Tomlinson G, Brill-Edwards P, Detsky A. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behaviors. JAMA. 2001; 286: 1994 – 9. | en_US |
dc.identifier.citedreference | Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982; 73: 4 – 8. | en_US |
dc.identifier.citedreference | Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998; 13: 151 – 4. | en_US |
dc.identifier.citedreference | Madhavan S, Amonkar MM, Elliott D, et al. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther. 1997; 22: 207 – 15. | en_US |
dc.identifier.citedreference | Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996; 5: 201 – 6. | en_US |
dc.identifier.citedreference | Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993; 22: 1593 – 6. | en_US |
dc.identifier.citedreference | Banks JW III, Mainous AG III. Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med. 1992; 67: 610 – 2. | en_US |
dc.identifier.citedreference | McKinney WP, Schiedermayer DL, Lurie N, et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990; 264: 1693 – 7. | en_US |
dc.identifier.citedreference | Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. CMAJ. 1995; 153: 553 – 9. | en_US |
dc.identifier.citedreference | Mick T. Pharmaceutical funding and medical students. JAMA. 1991; 265: 659. 662–4. | en_US |
dc.identifier.citedreference | Keim SM, Sanders AB. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with biomedical industry. Ann Emerg Med. 1993; 22: 1576 – 81. | en_US |
dc.identifier.citedreference | Sierles FS, Brodkey AC, Cleary LM, et al. Medical students’ exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005; 294: 1034 – 42. | en_US |
dc.identifier.citedreference | Mainous AG III, Hueston WJ, Rich EC. Patient perceptions of physician acceptance of gifts from pharmaceutical industry. Arch Fam Med. 1995; 4: 335 – 9. | en_US |
dc.identifier.citedreference | Blake RL, Early EK. Patients’ attitudes about gifts to physicians from pharmaceutical companies. J Am Board Fam Pract. 1995; 8: 457 – 64. | en_US |
dc.identifier.citedreference | Carroll AE, Vreeman RC, Buddenbaum J, Inui TS. To what extent do educational interventions impact medical trainees’ attitudes and behaviors regarding industry-trainee and industry-physician relationships? Pediatrics. 2007; 120: 1528 – 35. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.